Pierre Fabre Medicament

Nicolas Rahier

El Bachir Kaloun

Karim Bedjeguelal

Rémi Rabot

Michel Perez

Philippe Schmitt

Patrice Mayer

Arnaud Marchand

Anna Kruczynski

Frédéric Marion

Frédéric Lieby-Muller

Serge Grisoni

Hugues Bienayme

Isabelle Sartori

Emmanuel Fournier

Philippe Schambel

The present invention relates to compounds of the following general formula (I), or to a pharmaceutically acceptable salt thereof, as well as to the uses thereof as a drug, in particular in the treatment of cancerous or precancerous hyperproliferative conditions, and to the pharmaceutical compositions containing same. 

Griseofulvin derivatives

The present invention relates to compounds of following general formula (I): and to the pharmaceutically acceptable salts of same, the tautomers of same, the stereoisomers or mixture of stereoisomers in any proportions of same, such as a mixture of enantiomers, notably a racemic mixture, as well as to methods for preparing same and uses of same, notably as an antineoplastic agent. 

Tri- and tetracyclic pyrazolo[3,4-B]pyridine compounds as antineoplastic agent

The present invention concerns compounds of following general formula (I): (Formula I) and their pharmaceutically acceptable salts, their method of preparation and their uses, notably as anticancer agent. 

Pyrazolopyridine derivatives as anticancer agent

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same.

Substituted pyrazolo[3,4-b]pyridines as medicaments

Growing community of inventors

Ayguesvives, France

Nicolas Rahier